Glucagon-like peptide-1 agonists in children with obesity and type 2 diabetes. an umbrella review
GLP-1 agonists are a promising and effective therapy for lowering weight, HbA1c, BMI z, and SBP in adolescents with obesity or youth with type 2 DM. Moreover, GLP-1 agonists were well tolerated, and the total adverse events and hypoglycemia were comparable to those of controls.
Authors
- Laila A. AlBishi (ORCID: https://orcid.org/0000-0002-4677-3581)
- Hyder Mirghani
- Sawsan Mohmmad Alblewi
Institutions
- Ufuk University (TR)
- University of Tabuk (SA)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-02-19
- DOI
- https://doi.org/10.3389/fendo.2026.1777907
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00